Evaluation of popular drug information resources on clinically useful and actionable pharmacogenomic information

Background: Pharmacogenomics is the study of how genes affect a person’s response to drugs. This descriptive study assessed whether popular drug information resources provide clinically useful pharmacogenomic (PGx) information. Methods: Four resources (package inserts, Lexicomp, Micromedex 2.0, and...

Full description

Bibliographic Details
Main Authors: Jennifer S. Chang, Duyen-Anh Pham, Maithao T. Dang, Yiting Lu, Sheri VanOsdol, Jaekyu Shin
Format: Article
Language:English
Published: University Library System, University of Pittsburgh 2016-01-01
Series:Journal of the Medical Library Association
Subjects:
Online Access:http://jmla.pitt.edu/ojs/jmla/article/view/367
Description
Summary:Background: Pharmacogenomics is the study of how genes affect a person’s response to drugs. This descriptive study assessed whether popular drug information resources provide clinically useful pharmacogenomic (PGx) information. Methods: Four resources (package inserts, Lexicomp, Micromedex 2.0, and Epocrates) were evaluated for information about twenty-seven drugs. Results: There was wide variability of PGx information. Whereas Lexicomp included relevant PGx biomarker information for all 27 drugs, Epocrates did in less than 50% of the drugs. None of the resources had monographs that fully incorporated Clinical Pharmacogenomics Implementation Consortium (CPIC) recommendations in more than 30% of the drugs. Conclusion: Lexicomp appears to be most useful PGx drug information resource, but none of the resources are sufficient.
ISSN:1536-5050
1558-9439